Steve Beuchaw
Stock Analyst at Morgan Stanley
(2.00)
# 2,182
Out of 4,786 analysts
103
Total ratings
60%
Success rate
1.64%
Average return
Main Sectors:
Stocks Rated by Steve Beuchaw
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Downgrades: Equal-Weight | $52 → $49 | $40.15 | +23.14% | 2 | Jan 6, 2025 | |
| A Agilent Technologies | Initiates: Outperform | n/a | $116.98 | - | 20 | Dec 13, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $711 → $770 | $158.86 | +384.70% | 11 | Jul 29, 2021 | |
| BRKR Bruker | Upgrades: Peer Perform | n/a | $41.74 | - | 9 | Nov 16, 2020 | |
| HSIC Henry Schein | Upgrades: Outperform | $68 | $68.49 | -0.72% | 4 | Apr 2, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | $66 | $14.94 | +341.77% | 6 | Apr 2, 2020 | |
| ILMN Illumina | Maintains: Equal-Weight | $320 → $288 | $79.34 | +262.99% | 9 | Jan 7, 2019 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $254 → $260 | $497.60 | -47.75% | 7 | Oct 25, 2018 | |
| WAT Waters | Maintains: Equal-Weight | $204 → $211 | $368.57 | -42.75% | 13 | Oct 10, 2018 | |
| MYGN Myriad Genetics | Maintains: Overweight | $51 → $54 | $8.87 | +508.79% | 10 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $41 | $141.41 | -71.01% | 5 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $243.56 | +37.54% | 1 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $241.99 | +38.44% | 1 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $21 → $19 | $31.24 | -39.18% | 5 | Aug 31, 2018 | |
Qiagen
Jan 6, 2025
Downgrades: Equal-Weight
Price Target: $52 → $49
Current: $40.15
Upside: +23.14%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $116.98
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711 → $770
Current: $158.86
Upside: +384.70%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $41.74
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: $68
Current: $68.49
Upside: -0.72%
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: $66
Current: $14.94
Upside: +341.77%
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: $320 → $288
Current: $79.34
Upside: +262.99%
Thermo Fisher Scientific
Oct 25, 2018
Maintains: Overweight
Price Target: $254 → $260
Current: $497.60
Upside: -47.75%
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: $204 → $211
Current: $368.57
Upside: -42.75%
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: $51 → $54
Current: $8.87
Upside: +508.79%
Sep 28, 2018
Maintains: Overweight
Price Target: $21 → $41
Current: $141.41
Upside: -71.01%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $243.56
Upside: +37.54%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $241.99
Upside: +38.44%
Aug 31, 2018
Maintains: Underweight
Price Target: $21 → $19
Current: $31.24
Upside: -39.18%